Revive Therapeutics Ltd (RVVTF)

[tcm55]

Dont know what SoC will be given, but this is from the Trial info. I am willing to wait for well researched results from this interim data..

"Patients qualifying for study enrollment will initiate therapy as outpatients, under home quarantine. Patients will receive continued standard care of therapy (per study site written policies or guidelines) together with bucillamine and/ or matching placebo for up to 14 days. Dosing should continue until the treatment course is completed or as medically indicated (e.g., deterioration of clinical status and alternative therapy required). If the patient requires hospitalization during the study period, treatment will be discontinued."